Artwork

محتوای ارائه شده توسط Health Professional Radio. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Health Professional Radio یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
Player FM - برنامه پادکست
با برنامه Player FM !

Cancer Patient Experience with FDA Approved CAR T Therapy

8:55
 
اشتراک گذاری
 

بایگانی مجموعه ها ("فیدهای غیر فعال" status)

When? This feed was archived on October 25, 2022 13:32 (1+ y ago). Last successful fetch was on May 03, 2022 16:48 (2y ago)

Why? فیدهای غیر فعال status. سرورهای ما، برای یک دوره پایدار، قادر به بازیابی یک فید پادکست معتبر نبوده اند.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 286112554 series 1076397
محتوای ارائه شده توسط Health Professional Radio. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Health Professional Radio یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
Milton, a 68-year-old from Beulah, AL shares his experience of becoming 98 percent cancer free after his participation in a clinical trial for a recently FDA-approved CAR T cell therapy called BREYANZI® (lisocabtagene maraleucel) from Bristol-Myers Squibb. He was treated for a diffuse large B-cell lymphoma (DLBCL) – one of the most common types of non-Hodgkin’s lymphoma. Retired contractor-turned pastor, Auburn University sports fanatic and family man, Milton, was diagnosed with diffuse large B-cell lymphoma (DLBCL) – one of the most common types of non-Hodgkin’s lymphoma – in 2015. After failed chemotherapy, Milton enrolled in a clinical trial for the FDA approved CAR T cell therapy treatment called Breyanzi and a month later, was 98 percent cancer free. For Milton, it was his faith – including his faith in his treatment and care team – along with a strong family support system and winning attitude that helped him manage life since diagnosis: "You’ve got to have a belief system bigger than yourself; believe in what we don’t see."Today, Milton remains cancer free and has been able to witness life's most important moments, like the recent birth of his second great grandchild – something he never anticipated being a part of. When he’s not serving his local church community as a pastor, he enjoys hosting Auburn game days with his family – including two adopted children, seven grandchildren and two great grandchildren. Retired contractor-turned pastor, Auburn University sports fanatic and family man, Milton, was diagnosed with diffuse large B-cell lymphoma (DLBCL) – one of the most common types of non-Hodgkin’s lymphoma – in 2015. After failed chemotherapy, Milton enrolled in a clinical trial for the FDA approved CAR T cell therapy treatment called Breyanzi and a month later, was 98 percent cancer free. For Milton, it was his faith – including his faith in his treatment and care team – along with a strong family support system and winning attitude that helped him manage life since diagnosis: "You’ve got to have a belief system bigger than yourself; believe in what we don’t see."Today, Milton remains cancer free and has been able to witness life's most important moments, like the recent birth of his second great grandchild – something he never anticipated being a part of. When he’s not serving his local church community as a pastor, he enjoys hosting Auburn game days with his family – including two adopted children, seven grandchildren and two great grandchildren.
  continue reading

683 قسمت

Artwork
iconاشتراک گذاری
 

بایگانی مجموعه ها ("فیدهای غیر فعال" status)

When? This feed was archived on October 25, 2022 13:32 (1+ y ago). Last successful fetch was on May 03, 2022 16:48 (2y ago)

Why? فیدهای غیر فعال status. سرورهای ما، برای یک دوره پایدار، قادر به بازیابی یک فید پادکست معتبر نبوده اند.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 286112554 series 1076397
محتوای ارائه شده توسط Health Professional Radio. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Health Professional Radio یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
Milton, a 68-year-old from Beulah, AL shares his experience of becoming 98 percent cancer free after his participation in a clinical trial for a recently FDA-approved CAR T cell therapy called BREYANZI® (lisocabtagene maraleucel) from Bristol-Myers Squibb. He was treated for a diffuse large B-cell lymphoma (DLBCL) – one of the most common types of non-Hodgkin’s lymphoma. Retired contractor-turned pastor, Auburn University sports fanatic and family man, Milton, was diagnosed with diffuse large B-cell lymphoma (DLBCL) – one of the most common types of non-Hodgkin’s lymphoma – in 2015. After failed chemotherapy, Milton enrolled in a clinical trial for the FDA approved CAR T cell therapy treatment called Breyanzi and a month later, was 98 percent cancer free. For Milton, it was his faith – including his faith in his treatment and care team – along with a strong family support system and winning attitude that helped him manage life since diagnosis: "You’ve got to have a belief system bigger than yourself; believe in what we don’t see."Today, Milton remains cancer free and has been able to witness life's most important moments, like the recent birth of his second great grandchild – something he never anticipated being a part of. When he’s not serving his local church community as a pastor, he enjoys hosting Auburn game days with his family – including two adopted children, seven grandchildren and two great grandchildren. Retired contractor-turned pastor, Auburn University sports fanatic and family man, Milton, was diagnosed with diffuse large B-cell lymphoma (DLBCL) – one of the most common types of non-Hodgkin’s lymphoma – in 2015. After failed chemotherapy, Milton enrolled in a clinical trial for the FDA approved CAR T cell therapy treatment called Breyanzi and a month later, was 98 percent cancer free. For Milton, it was his faith – including his faith in his treatment and care team – along with a strong family support system and winning attitude that helped him manage life since diagnosis: "You’ve got to have a belief system bigger than yourself; believe in what we don’t see."Today, Milton remains cancer free and has been able to witness life's most important moments, like the recent birth of his second great grandchild – something he never anticipated being a part of. When he’s not serving his local church community as a pastor, he enjoys hosting Auburn game days with his family – including two adopted children, seven grandchildren and two great grandchildren.
  continue reading

683 قسمت

همه قسمت ها

×
 
Loading …

به Player FM خوش آمدید!

Player FM در سراسر وب را برای یافتن پادکست های با کیفیت اسکن می کند تا همین الان لذت ببرید. این بهترین برنامه ی پادکست است که در اندروید، آیفون و وب کار می کند. ثبت نام کنید تا اشتراک های شما در بین دستگاه های مختلف همگام سازی شود.

 

راهنمای مرجع سریع